Silver Book Fact

Mortality rate from hospital-acquired pneumonia

The mortality rate for hospital-acquired pneumonia ranges from 38% to more than 70%.

Laessig, Katherine A. End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration perspective. Clin Infect Dis. 2010; 181(6): 1897-905. http://cid.oxfordjournals.org/content/51/Supplement_1/S117.full

Reference

Title
End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration perspective
Publication
Clin Infect Dis
Publication Date
2010
Authors
Laessig, Katherine A.
Volume & Issue
Volume 181, Issue 6
Pages
1897-905
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Antibiotic resistance of Klebsiella pneumoniae on the rise
    Resistance of Klebsiella pneumoniae to antibiotics has dramatically increased- from 5.3% to 11.6% for third generation cephalosporins (between 1999 and 2010), and from <0.1% to 4.5% for carbapenams (between 2002…  
  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • ~70% of hospital HAIs resistant to ≥ antimicrobial
    Approximately 70% of hospital-acquired HAIs are resistant to at least one antimicrobial drug.  
  • ~3/4 of all HAIs occur outside of ICU
    Nearly 3/4 of all hospital-acquired HAIs occur outside of the intensive care unit (ICU).  
  • Antibacterial resistant pathogens responsible for most of 99,000 HAI related deaths
    The majority of the 99,000 patients who die from healthcare-associated infections each year, are due to antibacterial-resistant pathogens.